Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective

Background: Little is known about the costs associated with vitamin K antagonist (VKA) treatment in patients with non-valvular atrial fibrillation (NVAF) in France. Objectives: To evaluate monthly per-patient costs attributable to VKA treatment in NVAF patients from a French societal perspective. St...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Pierre, Smadja, David, Dorey, Julie, Toumi, Mondher, Meinecke, Anna-Katharina, Bowrin, Kevin, Briere, Jean-Baptiste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374971/
https://www.ncbi.nlm.nih.gov/pubmed/30788086
http://dx.doi.org/10.1080/20016689.2018.1564506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374971/
https://www.ncbi.nlm.nih.gov/pubmed/30788086
http://dx.doi.org/10.1080/20016689.2018.1564506

Ejemplares similares